Patients alive after more than three years from diagnosis with stage IV or Stage III NSCLC or SCLC, not treated with cytotoxic chemotherapy at the time of inclusion (the patient may be undergoing imunotherapy, targeted therapy or surveillance).
Patients covered by the French National Health Insurance program or with thirdparty-payer health insurance
You may not be if
Difficulties for understanding French
Patients undergoing treatment with cytotoxic chemotherapy
Patients under legal guardianship, under curatorship or tutorship
Insufficient cognitive capacity to answer questions
Inability to obtain data collection (lost to follow-up, patient's refusal for data collection)
Patients refusing the collection of their data (an information sheet will be provided)
Clareo Health | Long-Terms Responders in Metastatic Lung Cancer: Better Understanding for Better Management (Lungevity Study)
